IV 

116TH CONGRESS 

2D SESSION H. RES. 970 

Supporting the designation of May 2020 as ‘‘ALS Awareness Month’’. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 15, 2020 

Mr. CROW (for himself, Mr. FITZPATRICK, Ms. SEWELL of Alabama, Mr. CALVERT, Mr. DEUTCH, Mr. LARSON of Connecticut, Mr. KING of Iowa, Mr. 

CLAY, Mr. NEGUSE, Mr. HOLDING, Mr. O’HALLERAN, Mr. ROUDA, Mr. 

VAN DREW, Mr. RASKIN, Mr. HURD of Texas, Mr. QUIGLEY, Mrs. AXNE, 

Mr. MOULTON, Mr. CASTEN of Illinois, Mr. COLE, Mr. SCHIFF, Ms. CASTOR of Florida, Mr. RODNEY DAVIS of Illinois, Mr. FORTENBERRY, Mr. 

HUFFMAN, Mrs. RODGERS of Washington, Mr. GALLAGHER, Mr. CASE, 

Ms. BLUNT ROCHESTER, Mr. SUOZZI, Mr. CONNOLLY, Mr. LAMBORN, 

Mrs. DAVIS of California, Mr. PANETTA, Mr. ROSE of New York, Mr. 

MCGOVERN, Mr. JOHNSON of Georgia, Mr. THOMPSON of Mississippi, 

Mr. KING of New York, Mr. BOST, Mr. MARSHALL, Mr. WESTERMAN, 

Mr. PRICE of North Carolina, Mr. BILIRAKIS, Ms. VELA ́ZQUEZ, Ms. 

FINKENAUER, Mr. BIGGS, Mr. TRONE, Mr. BUTTERFIELD, Mrs. BEATTY, 

Mr. DEFAZIO, Ms. MATSUI, Mr. COHEN, Mr. JOYCE of Ohio, Mr. 

THOMPSON of Pennsylvania, Mr. WELCH, Mr. MAST, Mr. VARGAS, Mr. 

LAMB, Mr. TONKO, Mr. RUPPERSBERGER, Mr. ESPAILLAT, Mr. BISHOP

of Georgia, Mr. ENGEL, Ms. BONAMICI, Ms. ADAMS, Mr. LYNCH, Ms. 

MCCOLLUM, Ms. CRAIG, Mr. TIMMONS, Ms. LEE of California, Mr. 

CLEAVER, Mr. CURTIS, and Mrs. CAROLYN B. MALONEY of New York) 

submitted the following resolution; which was referred to the Committee 

on Energy and Commerce 

RESOLUTION 

Supporting the designation of May 2020 as ‘‘ALS Awareness 

Month’’. 

Whereas amyotrophic lateral sclerosis (referred to in this preamble as ‘‘ALS’’) is a progressive neurodegenerative disVerDate Sep 11 2014 02:27 May 16, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR970.IH HR970

kjohnson on DSK79L0C42PROD with BILLS
2 

•HRES 970 IH 

ease that affects nerve cells in the brain and the spinal 

cord; 

Whereas the life expectancy for an individual with ALS is between 2 and 5 years after the date on which the individual receives an ALS diagnosis; 

Whereas ALS occurs throughout the world with no racial, 

ethnic, gender, or socioeconomic boundaries; 

Whereas the 2 different types of ALS are sporadic ALS and 

familial ALS; 

Whereas sporadic ALS— 

(1) is the most common form of motor neuron disease in the United States; 

(2) accounts for between 90 and 95 percent of all 

cases of ALS in the United States; and 

(3) may affect any individual in any location; 

Whereas familial ALS (commonly known as ‘‘FALS’’)— 

(1) is inherited; and 

(2) accounts for between 5 and 10 percent of all 

cases of ALS in the United States; 

Whereas there is a 50 percent chance that each offspring of 

an individual with familial ALS will inherit the gene mutation for familial ALS and develop the disease; 

Whereas, on average, the period between the date on which 

an individual first experiences symptoms of ALS and the 

date on which the individual is diagnosed with ALS is 

about 1 year; 

Whereas the onset of ALS often involves muscle weakness or 

stiffness, and the progression of ALS results in the further weakening, wasting, and paralysis of— 

(1) the muscles of the limbs and trunk; and 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HRES 970 IH 

(2) the muscles that control vital functions, such as 

speech, swallowing, and breathing; 

Whereas ALS can strike individuals of any age but predominantly strikes adults; 

Whereas it is estimated that tens of thousands of individuals 

in the United States have ALS at any given time; 

Whereas, based on studies of the population of the United 

States, slightly more than 5,600 individuals in the United 

States are diagnosed with ALS each year, and 15 individuals in the United States are diagnosed with ALS each 

day; 

Whereas, between 2015 and 2040, the number of ALS cases 

around the world is expected to increase nearly 70 percent; 

Whereas the majority of individuals with ALS die of respiratory failure; 

Whereas military veterans are approximately twice as likely 

to be diagnosed with ALS as the general public in the 

United States; 

Whereas, as of the date of introduction of this resolution, 

there is no cure for ALS; 

Whereas the spouses, children, and family members of individuals living with ALS provide support to those individuals with love, day-to-day care, and more; and 

Whereas an individual with ALS and the caregivers of such 

an individual can be required to bear significant costs for 

medical care, equipment, and home health care services 

for the individual as the disease progresses: Now, therefore, be it 

1 Resolved, That the House of Representatives— 


kjohnson on DSK79L0C42PROD with BILLS
4 

•HRES 970 IH 

1 (1) supports the designation of ‘‘ALS Aware2 ness Month’’; 

3 (2) affirms the dedication of the House of Rep4 resentatives to working toward securing cures and 

5 better treatments for amyotrophic lateral sclerosis 

6 (referred to in this resolution as ‘‘ALS’’) as soon as 

7 possible; 

8 (3) recognizes the challenges that individuals 

9 with medically determined ALS face on a daily 

10 basis; and 

11 (4) commends the dedication of the family 

12 members, friends, organizations, volunteers, re13 searchers, and caregivers across the United States 

14 that are working to improve the quality and length 

15 of life of ALS patients. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS